MTOR and non-Hodgkin lymphoma: The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of the rapamycin (mTOR) cellular signaling pathway is important for cellular proliferation, metabolism, and survival, and it has been found to be dysregulated in non-Hodgkins lymphoma [42].